Current Research Projects at Gray Matters

There are those who use research, and those who contribute to it. At Gray Matters, we are proud to do both.

Concussion

Our pioneering qEEG concussion baseline program is gathering unprecedented data, which we are de-identifying and sharing with
other researchers.

This data has already been used by Neuroguide to improve the Network Injury Index.

Autism

Gray Matters has commenced a ground-breaking study combining audio entrainment with neurofeedback to target specific brain networks in autistic children.

Preliminary studies show great promise. A new round of study participants will be enrolled soon.

Peer-Reviewed Publications

A Comparison of EEG Biofeedback and Psychostimulants in Treating Attention Deficit/Hyperactivity Disorders
by Rossiter TR and La Vaque TJ


ABSTRACT
The study compared treatment programs with EEG biofeedback or stimulants as their primary components. An EEG group (EEG) was matched with a stimulant group (MED) by age, IQ, gender and diagnosis. The Test of Variables of Attention (TOVA) was administered pre and post treatment.
The Effects of Stimulant Therapy, EEG Biofeedback, and Parenting Style on the Primary Symptoms of Attention-Deficit/Hyperactivity Disorder [abs.]
by Monastra VJ, Monastra DM, George S


ABSTRACT
One hundred children, ages 6-19, who were diagnosed with attention-deficit/hyperactivity disorder (ADHD), either inattentive or combined types, participated in a study examining the effects of Ritalin, EEG biofeedback, and parenting style on the primary symptoms of ADHD.

View Publication
Neurofeedback Treatment for Attention Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate [abs.]
by Fuchs T, Birbaumer N, Lutzenberger W, Gruzelier J. H., & Kaiser J


ABSTRACT
Clinical trials have suggested that neurofeedback may be efficient in treating attention-deficit/hyperactivity disorder (ADHD). We compared the effects of a 3-month electroencephalographic feedback program providing reinforcement contingent on the production of cortical sensorimotor rhythm (12-15 Hz) and betal activity (15-18 Hz) with stimulant medication.

View Publication
The Effectiveness of Neurofeedback and Stimulant Drugs in Treating AD/HD: Part I. Review of Methodological Issues [abs.]
by Rossiter T.R.


ABSTRACT
The paper examines major criticisms of AD/HD (Attention Deficit/Hyperactivity Disorder) neurofeedback research using T. R. Rossiter and T. J. La Vaque (1995) as an exemplar and discusses relevant aspects of research methodology.

View Publication
The Effectiveness of Neurofeedback and Stimulant Drugs in Treating AD/HD: Part II. Replication [abs.]
by Rossiter T.R.


ABSTRACT
This study replicated T. R. Rossiter and T. J. La Vaque (1995) with a larger sample, expanded age range, and improved statistical analysis. Thirty-one ADIHD patients who chose stimulant drug (MED) treatment were matched with 31 patients who chose a neurofeedback (EEG) treatment program.

View Publication
Menu